Increasing prevalence of mouth ulcers coupled with growing awareness about mouth ulcers is the vital driver for the growth of mouth ulcers treatment market. Global prevalence rate of mouth ulcers is around 2% to 60%. Some other drivers for this market are growing geriatric population and easy availability of treatments products such as gels and lozenges. In addition, extensive presence of promotional activity programs is expected to drive the market during the forecast period.
Mouth ulcers treatment market is classified into three broad segments based on the type of drug class, dosage form and indication. On the basis of type of drug class, the market is segmented into corticosteroids, analgesics, anesthetics, antimicrobials and antihistaminic. Mouthwash, spray, gels and lozenges are the dosage forms of this market. Gels market dominated the overall market in 2013. Gels are the first line treatment and are mostly preferred by patients. Lozenge segment market is expected to show a lucrative CAGR during the forecast period owing to the advantages associated with these products such as low cost and easy availability. Based on indications, the market is divided into oral lichen planus, aphthous stomatitis and others. Aphthous stomatitis segment held the largest market share in terms of revenue in 2013 and is expected to grow at a significant growth rate in the coming six years. Growing prevalence rate and high market penetration of these products are the factors attributing for its lucrative growth.
Geographically, mouth ulcers treatment market is divided into four regions such as North America, Europe, Asia Pacific and RoW. North America dominated the overall market in terms of revenue owing to the increasing prevalence of mouth ulcers and growing demand for ulcers treatment. According to the Journal of Oral Pathology and Medicine, in 2013, around 49.7% women and 38.7% men were suffering from aphthous stomatitis in U.S. Asia Pacific is expected to witness a lucrative growth during the next six years owing the rising healthcare expenditure and increasing patient awareness level. Major players for mouth ulcers treatment market include 3M Healthcare, Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight Co. Inc., ECR Pharmaceuticals, Henry Schein Inc., Novartis Pharmaceuticals Corp. and Macoven Pharmaceuticals.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."